n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine has been researched along with Adjuvant Arthritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baharav, E; Bar-Yehuda, S; Fishman, P; Halpren, M; Madi, L; Ochaion, A; Rath-Wolfson, L; Silberman, D; Weinberger, A | 1 |
| Baharav, E; Bar-Yehuda, S; Cohen, S; Fishman, P; Madi, L; Ochaion, A; Rath-Wolfson, L | 1 |
2 other study(ies) available for n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and Adjuvant Arthritis
| Article | Year |
|---|---|
Antiinflammatory effect of A3 adenosine receptor agonists in murine autoimmune arthritis models.
Topics: Adenosine; Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Collagen; Dose-Response Relationship, Drug; Female; Joints; Lymph Nodes; Male; Mice; Mice, Inbred DBA; Quinazolines; Rats; Receptor, Adenosine A3; Spleen; Triazoles; Tumor Necrosis Factor-alpha | 2005 |
The PI3K-NF-kappaB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritis.
Topics: Adenosine; Adenosine A3 Receptor Antagonists; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Female; Intracellular Signaling Peptides and Proteins; Lymph Nodes; Monocytes; NF-kappa B; Phosphatidylinositol 3-Kinases; Rats; Rats, Inbred Lew; Severity of Illness Index; Signal Transduction; Synovial Membrane | 2006 |